LEADER 03229nam 2200577Ia 450 001 9910841735503321 005 20230721033050.0 010 $a0-470-77277-8 010 $a1-281-84105-6 010 $a9786611841058 010 $a0-470-77278-6 035 $a(CKB)1000000000550908 035 $a(EBL)366790 035 $a(OCoLC)476201870 035 $a(SSID)ssj0000125974 035 $a(PQKBManifestationID)11133850 035 $a(PQKBTitleCode)TC0000125974 035 $a(PQKBWorkID)10030136 035 $a(PQKB)11139256 035 $a(MiAaPQ)EBC366790 035 $a(EXLCZ)991000000000550908 100 $a20080314d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aCommunity acquired pneumonia$b[electronic resource] $estrategies for management /$fedited by Antoni Torres and Rosario Menendez 210 $aChichester, England ;$aHoboken, NJ $cJohn Wiley & Sons$dc2008 215 $a1 online resource (287 p.) 300 $aDescription based upon print version of record. 311 $a0-470-05809-9 320 $aIncludes bibliographical references and index. 327 $aCommunity-Acquired Pneumonia; Contents; Preface; List of Contributors; 1 Epidemiology of Community-Acquired Pneumonia Outside Hospital; 2 Epidemiology of Adult Hospitalized Community-Acquired Pneumonia; 3 Microbial Aetiology and Antibiotic Resistances in Community-Acquired Pneumonia; 4 Microbiological Diagnosis of Community-Acquired Pneumonia; 5 Empirical Treatment of Community-Acquired Pneumonia: Current Guidelines; 6 Pathogen Directed Antimicrobial Treatment of Pneumonia; 7 General Pharmacological Considerations in Antibiotic Treatment of Community-Acquired Pneumonia 327 $a8 ?-Lactams in the Therapy of Community-Acquired Pneumonia9 Macrolides and Ketolides; 10 Role of Fluoroquinolones in the Treatment of Community-Acquired Pneumonia; 11 Non-Responding Pneumonia; 12 Influenza and Pneumococcal Vaccination for Prevention of Community-Acquired Pneumonia in Immunocompetent Adults; 13 Adjunctive Therapy in Community-Acquired Pneumonia; Index 330 $aCommunity-Acquired Pneumonia (CAP) refers to pneumonia acquired outside of hospitals or extended-care facilities, and is distinct from Nosocomial or hospital-acquired pneumonia, which is a separate disease entity. It is one of the most common respiratory infections and presents one of the major health problems today, with an incidence that ranges from eight to fifty cases per thousand individuals each year. Mortality is still very high and yet the risk factors are very well known. Many of these are related to antibiotic treatment; delay in administration, inadequacy of empiric antibioti 606 $aCommunity-acquired pneumonia 606 $aPneumonia 615 0$aCommunity-acquired pneumonia. 615 0$aPneumonia. 676 $a616.2/41 676 $a616.241 701 $aTorres Marti?$b A$g(Antoni)$0789378 701 $aMenendez$b Rosario$01727051 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910841735503321 996 $aCommunity acquired pneumonia$94133763 997 $aUNINA